BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7047346)

  • 21. Effects of physiological infusion of epinephrine in normal humans: relationship between the metabolic response and beta-adrenergic binding.
    Soman VR; Shamoon H; Sherwin RS
    J Clin Endocrinol Metab; 1980 Feb; 50(2):294-7. PubMed ID: 6243667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic adaptation to prolonged exercise in severely obese subjects.
    Scheen AJ; Pirnay F; Luyckx AS; Lefebvre PJ
    Int J Obes; 1983; 7(3):221-9. PubMed ID: 6885230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic responses to intense exercise in lean and obese subjects.
    Yale JF; Leiter LA; Marliss EB
    J Clin Endocrinol Metab; 1989 Feb; 68(2):438-45. PubMed ID: 2645309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of somatostatin on epinephrine-induced free fatty acid release in normal man.
    Botha JL; Vinik AI; Child P; Lund A; van Tonder S
    S Afr Med J; 1977 Dec; 52(25):995-7. PubMed ID: 607511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Furosemide intravenous infusion in normal man: electrolytic, metabolic and hormonal effects. Lack of changes in basal insulin and glucagon plasma levels.
    Luyckx AS; Mendoza E; Lefebvre P
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):305-13. PubMed ID: 7013722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of glucagon in mediating metabolic effects of epinephrine.
    Chideckel EW; Goodner CJ; Koerker DJ; Johnson DG; Ensinck JW
    Am J Physiol; 1977 May; 232(5):E464-70. PubMed ID: 404888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The behaviour of some biologic parameters in obese patients after short-term exercise under restrictive diets.
    Dumitrescu C; Mihalache N; Mirodon Z; Perianu S
    Med Interne; 1981; 19(2):199-204. PubMed ID: 7022609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma levels of glucagon-like polypeptides in gastrectomized patients transformed from Billroth II into Billroth I.
    Tamburrano G; Mauceri M; Lala A; Tonelli F; Leonetti F; Andreani D
    Horm Metab Res; 1982 Dec; 14(12):642-5. PubMed ID: 7152478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.
    Shahshahani MN; Kitabchi
    J Clin Endocrinol Metab; 1978 Jul; 47(1):34-40. PubMed ID: 400713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man.
    Wise JK; Hendler R; Felig P
    J Clin Invest; 1973 Nov; 52(11):2774-82. PubMed ID: 4748510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin synthesis inhibitors impair hepatic glucose production in response to glucagon and epinephrine stimulation.
    Miller JD; Ganguli S; Sperling MA
    Diabetes; 1983 May; 32(5):439-44. PubMed ID: 6301913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary and plasma cyclic AMP levels during short term starvation in obese man: response to glucagon stimulation.
    Turpin BP; Austin MW; Solomon SS
    Horm Metab Res; 1978 Jan; 10(1):36-7. PubMed ID: 204564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of catecholamines on plasma free fatty acids in fed and fasted cattle.
    Blum JW; Froehli D; Kunz P
    Endocrinology; 1982 Feb; 110(2):452-6. PubMed ID: 7056209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating amino acids and pancreatic endocrine function after ingestion of a protein-rich meal in obese subjects.
    Schmid R; Schusdziarra V; Schulte-Frohlinde E; Maier V; Classen M
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1106-10. PubMed ID: 2656733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucoregulatory role of cortisol and epinephrine interactions studied in adrenalectomized dogs.
    Gauthier C; el-Tayeb K; Vranic M; Lickley HL
    Am J Physiol; 1986 Apr; 250(4 Pt 1):E393-401. PubMed ID: 3515964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desensitization of beta-receptor mediated responses to epinephrine in fetal lambs by prolonged ritodrine administration.
    Bassett JM; Weeding CM; Hanson C
    Pediatr Res; 1990 Oct; 28(4):388-93. PubMed ID: 2172902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in plasma glucose, insulin (IRI), glucagon (IRG) and free fatty acids (FFA) following alanine loading in hyperthyroid patients.
    Ida H; Yamamoto T; Ninomiya H; Sasaki H; Asano T; Okumura M
    Endocrinol Jpn; 1987 Dec; 34(6):937-45. PubMed ID: 3330025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The involvement of the opioid system in human obesity: a study in normal weight relatives of obese people.
    Cozzolino D; Sessa G; Salvatore T; Sasso FC; Giugliano D; Lefebvre PJ; Torella R
    J Clin Endocrinol Metab; 1996 Feb; 81(2):713-8. PubMed ID: 8636293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in lipolytic sensitivity following repeated epinephrine infusion in humans.
    Townsend RR; Klein S; Wolfe RR
    Am J Physiol; 1994 Feb; 266(2 Pt 1):E155-60. PubMed ID: 8141272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of carbohydrate to spare leucine oxidation in obese subjects.
    Nair KS; Halliday D; Ford GC; Heels S; Garrow JS
    Int J Obes; 1987; 11(5):537-44. PubMed ID: 3323087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.